NEWMONT Corp /DE/
NEWMONT Corp /DE/ (NEM) Stock News
The latest NEM headlines and market coverage — 7 recent stories, updated throughout the day.
- Zacks Investment Research·Neutral
Newmont (NEM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Newmont Corporation reported Q3 2026 revenue of $6.36 billion, up 15.2% year-over-year, beating the consensus estimate of $6.01 billion by 5.87%. EPS came in at $2.20 versus the estimate of $1.94, representing a 13.4% surprise. However, total gold production of 1,302 Koz fell slightly short of analyst estimates of 1,317.21 Koz. The stock has declined 5.2% over the past month and carries a Zacks Rank #3 (Hold) rating.
- Zacks Investment Research·Neutral
Newmont Corporation (NEM) Is a Trending Stock: Facts to Know Before Betting on It
Newmont Corporation (NEM), a gold and copper miner, has declined 9.6% over the past month, underperforming the S&P 500. The company shows strong earnings growth expectations (+31.9% for current fiscal year) and revenue growth forecasts (+14.5% for current fiscal year), with a history of beating EPS estimates. However, it carries a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the broader market. The stock trades at a valuation discount to peers (Value Style Score: B).
- GlobeNewswire Inc.·
ONEMAIN FINANCIAL DATA BREACH: Edelson Lechtzin LLP Launches Investigation Into Exposure of Social Security Numbers
OneMain Financial, a consumer lending company with 1,400+ branches across 44 states, suffered a data breach in May 2026 that exposed names, addresses, and Social Security numbers of at least 16,988 individuals across multiple states. The breach was disclosed to authorities in September 2026. Edelson Lechtzin LLP is investigating potential class action claims to determine if the company failed to implement adequate cybersecurity safeguards.
- GlobeNewswire Inc.·
argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline
argenx presented new clinical data at the AANEM and MGFA scientific sessions demonstrating deepening improvements in ocular myasthenia gravis (MG) with VYVGART, sustained one-year efficacy in anti-AChR antibody-negative MG patients, and benefits of earlier treatment initiation. Real-world evidence from over 1,100 U.S. MG patients showed greater clinical gains when treatment started within one year of diagnosis. Long-term CIDP data reinforced consistent safety and efficacy, with a Phase 4 study supporting direct transition from IVIg. Pipeline candidates empasiprubart and adimanebart showed promising Phase 2 results in multifocal motor neuropathy and congenital myasthenic syndrome respectively.
- GlobeNewswire Inc.·
SKY BLUE CINEMATIX - ENTERTAINMENT - BRAND INTEGRATION : Two Films. One Global Partnership.
Sky Blue Cinematix has been appointed as the exclusive worldwide brand-integration partner for two upcoming feature films from Tested Films: the action thriller 'Habeas Corpus' and the neo-noir romantic mystery 'Blurred', both directed by Ben Cookson. The partnership will connect international brands with these theatrical productions through in-film integration across all territories.
- Zacks Investment Research·
Can NEM Maintain Earnings Momentum Amid Production Challenges?
Newmont Corporation (NEM) reported a 13% year-over-year decline in Q2 gold production to 1.29 million ounces, with 2026 guidance showing further production decline to 5.26 million ounces. The company expects significantly higher all-in-sustaining costs of $1,680 per ounce in 2026 compared to $1,358 in 2025, driven by lower volumes, higher royalties, and deferred capital. Competitors Barrick Gold and Agnico Eagle showed mixed results with sequential production gains but facing their own challenges.
- Zacks Investment Research·
Is Newmont (NEM) a Buy as Wall Street Analysts Look Optimistic?
The article examines the reliability of Wall Street analyst recommendations versus Zacks Rank for stock picking. Using Newmont Corporation as an example, it highlights that brokerage firms show strong positive bias in their ratings (5 Strong Buys for every Strong Sell), making them less reliable than Zacks Rank, which is based on earnings estimate revisions and has a proven track record of outperforming the S&P 500.